Neelikon upgrades its laboratories
Neelikon has recently made improvements at its factory in Dhatav, near Mumbai
Author
‘We recorded a growth of around 15% last fiscal’
Ritvik V Saraf, MD, REMI Group, speaks about his company's offerings for the pharma sector and its growth plans, in an interaction…
MoHFW, NCC-PvPI to launch Pv training programme
First course from Jan 16-25, last date to apply extended to December 30
Complex generics: Charting a new path
A QuintilesIMS report finds that complex generics is a lucrative market for drug manufacturers, but only if they can adapt to a…
IL-17 inhibitors will drive psoriatic arthritis market to $12.6 bn by 2025: GlobalData
The relatively strong growth will primarily be driven by the increase in diagnosed prevalent cases
Asia-Pacific anti-hypertensive therapeutics market to hit $ 27 bn dollars by 2022: GBI Research
Growth will not be aided by the weak anti-hypertensive pipeline, due to lack of innovative products in late-stage development
Sun Pharma completes acquisition of JSC Biosintez
Russia-based Biosintez focuses on the hospital segment with annual revenues of about $52 million for 2015
Experts examine the strategies for a new VUCA WORLD
Featuring
- Jawed Zia, Novartis India
- Mike Warmuth, Abbott
- Daara Patel, IDMA
- Dr Ajit Dangi, Danssen Consulting
- Utkarsh…
Embracing change: Crucial to success in a VUCA world
Jawed Zia, Country President, Novartis India, advises pharma leaders to constantly evaluate their skills and course correct to…
India: The pulse of healthcare in emerging economies
India was among the first countries in which Abbott expanded outside the US, way back in 1910. Today, more than 85 per cent of…